The linearity of the effect of PSA slope on the risk of developing prostate cancer was likewise confirmed in the present study, demonstrating an increased prostate cancer risk for PSA slopes ranging between 0.5 and 3.5 ng/mL/year (Fig. 2). Here, KLK3 is linked to prostate cancer.